Sp368
PANEL DISCUSSION WITH Q&A
Date
May 7, 2023
Explore related products in the following collection:
Tracks
Related Products
POLYPHARMACY IS ASSOCIATED WITH OVERT HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS
BACKGROUND: Due to development of an immune dysregulated phenotype, advanced liver disease in all its forms predisposes to sepsis acquisition and related mortality…
NON-INVASIVE PREDICTION OF HIGH-RISK ESOPHAGEAL VARICES VIA ELECTROCARDIOGRAM-BASED DEEP LEARNING MODEL
BACKGROUND: Cirrhosis is a major contributor of morbidity and mortality in patients with chronic liver disease globally…
GLOBAL EPIDEMIOLOGY OF CIRRHOSIS: CHANGING ETIOLOGICAL BASIS AND DISEASE BURDEN BETWEEN FEMALES AND MALES
BACKGROUND: Cirrhosis is a major contributor of morbidity and mortality in patients with chronic liver disease globally…
COMPARISON IN THE MANAGEMENT OF GASTRIC VARICEAL BLEEDING: ENDOSCOPIC VARICEAL LIGATION VERSUS TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) VERSUS BALLOON-OCCLUDED RETROGRADE TRANSVENOUS OBLITERATION (BRTO): A FOUR-YEAR NATIONAL COHORT ANALYSIS
BACKGROUND: Cirrhosis is a major contributor of morbidity and mortality in patients with chronic liver disease globally…